XFLH Capital signs letter of intent to combine with Renogen Biolab
XFLH Capital entered into a Letter of Intent with Renogen Biolab for a proposed business combination, with due diligence access and efforts to negotiate definitive agreements.
XFLH Capital entered into a Letter of Intent with Renogen Biolab for a proposed business combination. The parties will use reasonable best efforts to negotiate definitive agreements and will provide reciprocal access for due diligence. A press release announcing the LOI was issued on Sep 22, 2026…